Bolt Medical

Bolt Medical is pioneering a new generation of Intravascular Lithotripsy (IVL) technology designed to address significant unmet needs in treating calcified cardiovascular disease. Its core innovation is a laser-based platform that generates precise acoustic pressure waves to crack calcium lesions, with claimed advantages in deliverability, therapy availability, and targeted energy delivery. While the device is currently investigational and not yet cleared for commercial sale, it targets the large and growing market of patients with calcified coronary and peripheral artery disease, positioning itself as a potential disruptor in a space currently led by Shockwave Medical.

Laser-based intravascular lithotripsy (IVL) platform. Laser energy is transmitted via optical fibers and converted to precise acoustic pressure waves within a balloon to fracture vascular calcium.

The IVL market is currently dominated by Shockwave Medical (acquired by Johnson & Johnson). Other competitors include traditional atherectomy devices (Rotablator, Orbital Atherectomy) and specialty balloons. Bolt's primary competition is Shockwave, against which it must prove superior efficacy, usability, or cost to gain adoption.